deltatrials
Active Not Recruiting OBSERVATIONAL NCT07088471

Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan (CLEAR)

Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan: The CLEAR Study.

Sponsor: Connolly Hospital Blanchardstown

Conditions Heart Failure and Reduced Ejection Fraction
Interventions Sacubtril/Valsartan
Updated 2 times since 2025 Last updated: Aug 1, 2025 Started: Nov 1, 2024 Primary completion: May 1, 2025 Completion: Aug 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07088471, this observational or N/A phase trial focuses on Heart Failure and Reduced Ejection Fraction and remains ongoing. Sponsored by Connolly Hospital Blanchardstown, it has been updated 2 times since 2024, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshotActive Not Recruiting

Change History

2 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting

  2. Aug 2025 — Sep 2025 [monthly]

    Active Not Recruiting

    First recorded

Nov 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Connolly Hospital Blanchardstown
Data source: Connolly Hospital Blanchardstown

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations